will be interesting to see if this 5.4m buy @ 15c goes through on the bell... yesterdy someone wanted out and by the looks of it someone else wants in.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
